Sein métastatique RH+
CT7001_003 (SUMIT ELA)
A Phase 1b/2 Open-label Study of Samuraciclib in Combination with Elacestrant in;Participants with Metastatic or Locally Advanced Hormone Receptor-positive and Human;Epidermal Growth Factor Receptor 2-negative Breast Cancer.
Saint-Cloud
FRANCOIS-CLEMENT BIDARD